The editors of Cancer Today share impactful reporting and writing on cancer research and care from 2025.

by Cancer Today staff

Immune checkpoint inhibitor improves survival in people with limited-stage small cell lung cancer.

by Taneia Surles

Proton therapy for oropharyngeal cancer increases overall survival, and risk-based screening for breast cancer appears to be as effective as annual screening.

by Marci A. Landsmann

Clinical trial presented at SABCS finds some patients may safely skip sentinel lymph node biopsy.

by Thomas Celona

Maintenance treatment with an oral selective estrogen receptor degrader reduced recurrence in early-stage hormone receptor-positive breast cancers.

by Marci A. Landsmann

The addition of targeted therapy helps control metastatic breast cancer, and a pair of immunotherapy drugs prolongs survival in multiple myeloma.

by Thomas Celona

SABCS educational session highlights how alcohol and obesity can raise the risk for breast cancer.

by Thomas Celona

Research continues to show efficacy of HPV vaccines at preventing cervical cancer, and the FDA approves an immunotherapy for use before and after surgery for stomach cancers.

by Eric Fitzsimmons

Research suggests finding blood in stool is often an indicator of colorectal cancer.

by Kyle Bagenstose

80% of eligible Americans do not get annual lung cancer screenings, and breast cancer risk varies by type of hormonal birth control used.

by Darlene Dobkowski